October 24, 2015 Novartis wins approval for first US biosimilar drug U.S. regulators on Friday gave a green light to sales of the country's first copied version of a biotechnology drug, or "biosimilar," with approval of Novartis' white blood cell-boosting Zarxio.
October 24, 2015 FDA approves Bristol Myers Squibb’s Opdivo for lung cancer U.S. regulators approved Bristol-Myers Squibb Co. ’s advanced lung cancer drug Opdivo, the latest of a string of events that has focused efforts on using the immune system to battle the disease.
October 24, 2015 Spider venom may hold chemical keys to new painkillers Scientists who analyzed countless chemicals in spider venom say they have identified seven compounds that block a key step in the body's ability to pass pain signals to the brain.
October 24, 2015 No link between 'too many vaccines' and autism risk Despite concerns by some parents that their children receive “too many vaccines too soon,” a new study finds that many shots, even on the same day, do not increase the risk of autism
October 24, 2015 Nexium, Advair led Medicare drug spending in 2013, officials report Four brand-name medications accounted for almost one-tenth of the $103 billion in prescriptions filled by older or disabled Americans under Medicare's drug program in 2013, U.S. officials reported on Thursday.
October 24, 2015 FDA approves breakthrough cholesterol drug for high-risk patients The Food and Drug Administration on Friday approved a first-of-a-kind drug that lowers artery-clogging cholesterol more than older drugs that have been prescribed for decades.
October 24, 2015 Flu vaccine prevented 13 million illnesses over 6 years Seasonal flu shots have prevented about 13.6 million cases of illness over the last six years, according to new estimates from researchers at the Centers for Disease Control and Prevention (CDC)
October 24, 2015 Roche breast cancer drug 'unprecedented' in extending lives A new breast cancer drug from Roche has shown "unprecedented" benefits in extending lives in a clinical trial and experts urged its widespread use for women with an aggressive form of the disease.
October 24, 2015 Geography affects what drugs seniors are prescribed Where seniors live makes a difference not only in how much health care they receive but also the medications they're prescribed - as some miss out on key treatments while others get risky ones, new research shows.
October 24, 2015 New cancer drugs 'vastly overestimated,' says contrarian analyst A hot new class of drugs designed to help the body's own immune system fend off cancer by blocking a protein called PD-1 is going to be big— but not nearly as big as investors think, according to a new analysis.